Bharat Biotech says typhoid vaccine shown to be safe, effective in human trialsPost published:October 2, 2017Post category:Industry NewsClinical studies showed 87% effectiveness for Typbar-TCV typhoid vaccine, says Bharat Biotech Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMeet the Man Who Designed Your iPhone (It Wasn’t All Steve Jobs) Next PostD-Mart’s rising brand value shows that hyperlocal pays You Might Also Like Govt raises concerns over dip in revenue from telcos March 1, 2017 Additive Manufacturing Materials: 3D Printing's Greatest Challenge September 17, 2019 Servitization for Sensors: Is S2aaS a viable business model? May 9, 2019